Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 03-May-22 8:58 PM View:  | Acadia Pharmaceuticals Inc. (ACAD) | 02-May-22 | Option Sale | 5,483 | $18.18 | $99,691.40 | (7%) 81.36K to 75.88K | |
| 03-May-22 8:58 PM View: | Acadia Pharmaceuticals Inc. (ACAD) | 29-Apr-22 | Option Exercise | 15,625 | -- | -- | 24% 65.73K to 81.36K | |
| 25-Feb-22 5:40 PM View: | Acadia Pharmaceuticals Inc. (ACAD) | 23-Feb-22 | Option Exercise | 10,945 | -- | -- | 19% 58.72K to 69.66K | |
| 25-Feb-22 5:40 PM View: | Acadia Pharmaceuticals Inc. (ACAD) | 23-Feb-22 | Option Sale | 3,928 | $23.80 | $93,486.40 | (6%) 69.66K to 65.73K | |
| 10-Jan-22 6:22 PM View: | Acadia Pharmaceuticals Inc. (ACAD) | 06-Jan-22 | Option Exercise | 9,527 | -- | -- | 18% 52.91K to 62.43K | |
| 10-Jan-22 6:22 PM View: | Acadia Pharmaceuticals Inc. (ACAD) | 06-Jan-22 | Market Option Sale | 3,718 | $23.05 | $85,699.90 | (6%) 62.43K to 58.72K | |
| 06-Jan-22 9:31 AM View: | Bellicum Pharmaceuticals, Inc (BLCM) | 04-Jan-22 | Option Exercise | 18,715 | -- | -- | 100% 0 to 18.71K | |
| 23-Dec-21 6:55 PM View: | AP Pharma Inc. (HRTX) | 22-Dec-21 | Grant | 10,452 | -- | -- | 348% 3.0K to 13.45K | |
| 19-Oct-21 5:30 PM View: | Acadia Pharmaceuticals Inc. (ACAD) | 18-Oct-21 | Market Option Sale | 2,963 | $17.41 | $51,585.80 | (5%) 55.87K to 52.91K | |
| 19-Oct-21 5:30 PM View: | Acadia Pharmaceuticals Inc. (ACAD) | 15-Oct-21 | Option Exercise | 5,938 | -- | -- | 12% 49.93K to 55.87K | |
| 30-Apr-21 6:52 PM View: | Acadia Pharmaceuticals Inc. (ACAD) | 30-Apr-21 | Market Option Sale | 7,850 | $20.33 | $159,590.00 | (14%) 57.16K to 49.31K | |
| 30-Apr-21 6:52 PM View: | Acadia Pharmaceuticals Inc. (ACAD) | 29-Apr-21 | Option Exercise | 15,625 | -- | -- | 38% 41.54K to 57.16K | |
| 08-Feb-21 9:00 PM View: | Acadia Pharmaceuticals Inc. (ACAD) | 04-Feb-21 | Grant | 31,250 | -- | -- | 264% 11.85K to 43.09K | |
| 08-Feb-21 9:00 PM View: | Acadia Pharmaceuticals Inc. (ACAD) | 04-Feb-21 | Market Sale | 14,195 | $50.61 | $718,409.00 | (33%) 43.09K to 28.9K | |
| 08-Jan-21 7:28 PM View: | Acadia Pharmaceuticals Inc. (ACAD) | 06-Jan-21 | Option Exercise | 9,527 | -- | -- | 52% 18.44K to 27.97K | |
| 08-Jan-21 7:28 PM View: | Acadia Pharmaceuticals Inc. (ACAD) | 06-Jan-21 | Market Option Sale | 3,484 | $53.34 | $185,837.00 | (12%) 27.97K to 24.48K | |
| 23-Dec-20 4:20 PM View: | AP Pharma Inc. (HRTX) | 21-Dec-20 | Grant | 3,000 | -- | -- | 100% 0 to 3.0K | |
| 19-Oct-20 5:25 PM View: | Acadia Pharmaceuticals Inc. (ACAD) | 16-Oct-20 | Market Option Sale | 2,960 | $42.56 | $125,978.00 | (17%) 17.75K to 14.79K | |
| 19-Oct-20 5:25 PM View: | Acadia Pharmaceuticals Inc. (ACAD) | 15-Oct-20 | Option Exercise | 5,937 | -- | -- | 50% 11.81K to 17.75K | |
| 15-May-20 7:11 PM View: | Acadia Pharmaceuticals Inc. (ACAD) | 14-May-20 | Option Exercise | 88,542 | $19.65 | $1,739,850.00 | 750% 11.81K to 100.35K | |
| 15-May-20 7:11 PM View: | Acadia Pharmaceuticals Inc. (ACAD) | 14-May-20 | Market Option Sale (Planned) | 88,542 | $45.62 | $4,039,100.00 | (88%) 100.35K to 11.81K | |
| 15-May-20 7:11 PM View: | Acadia Pharmaceuticals Inc. (ACAD) | 13-May-20 | Option Exercise | 111,458 | $19.65 | $2,190,150.00 | 944% 11.81K to 123.27K | |
| 15-May-20 7:11 PM View: | Acadia Pharmaceuticals Inc. (ACAD) | 13-May-20 | Market Option Sale (Planned) | 111,458 | $46.35 | $5,165,590.00 | (90%) 123.27K to 11.81K | |
| 01-May-20 6:00 PM View: | Acadia Pharmaceuticals Inc. (ACAD) | 30-Apr-20 | Market Option Sale | 6,770 | $49.21 | $333,152.00 | (36%) 18.58K to 11.81K | |
| 01-May-20 6:00 PM View: | Acadia Pharmaceuticals Inc. (ACAD) | 29-Apr-20 | Option Exercise | 15,625 | -- | -- | 529% 2.95K to 18.58K | |
| 06-Dec-19 6:25 PM View: | Acadia Pharmaceuticals Inc. (ACAD) | 05-Dec-19 | Option Exercise | 150,000 | $19.65 | $2,947,500.00 | 5078% 2.95K to 152.95K | |
| 06-Dec-19 6:25 PM View: | Acadia Pharmaceuticals Inc. (ACAD) | 05-Dec-19 | Market Option Sale (Planned) | 150,000 | $52.34 | $7,851,300.00 | (98%) 152.95K to 2.95K | |
| 17-Oct-19 6:23 PM View: | Acadia Pharmaceuticals Inc. (ACAD) | 15-Oct-19 | Option Exercise | 5,937 | -- | -- | 100% 0 to 5.94K | |
| 17-Oct-19 6:23 PM View: | Acadia Pharmaceuticals Inc. (ACAD) | 15-Oct-19 | Market Option Sale | 2,983 | $39.65 | $118,276.00 | (50%) 5.94K to 2.95K | |
| 11-Oct-19 5:39 PM View: | Acadia Pharmaceuticals Inc. (ACAD) | 10-Oct-19 | Option Exercise | 120,208 | $19.65 | $2,362,090.00 | 100% 0 to 120.21K | |
| 11-Oct-19 5:39 PM View: | Acadia Pharmaceuticals Inc. (ACAD) | 10-Oct-19 | Market Option Sale (Planned) | 120,208 | $40.19 | $4,831,040.00 | (100%) 120.21K to 0 | |
| 11-Oct-19 5:39 PM View: | Acadia Pharmaceuticals Inc. (ACAD) | 09-Oct-19 | Option Exercise | 29,792 | $19.65 | $585,413.00 | 100% 0 to 29.79K | |
| 11-Oct-19 5:39 PM View: | Acadia Pharmaceuticals Inc. (ACAD) | 09-Oct-19 | Market Option Sale (Planned) | 29,792 | $40.00 | $1,191,710.00 | (100%) 29.79K to 0 | |
| 30-Sep-14 6:41 PM View: | AP Pharma Inc. (HRTX) | 26-Sep-14 | Payment of Exercise | 102,634 | $8.44 | $866,231.00 | (84%) 122.71K to 20.08K | (227%) |
| 30-Sep-14 6:41 PM View: | AP Pharma Inc. (HRTX) | 26-Sep-14 | Option Exercise | 120,313 | $7.20 | $866,254.00 | 5019% 2.4K to 122.71K | |
| 07-Jul-14 4:38 PM View: | Furiex Pharmaceuticals, Inc. (FURX) | 02-Jul-14 | Disposition | 9,308 | -- | -- | (100%) 9.31K to 0 | |
| 04-Mar-14 6:46 PM View: | Furiex Pharmaceuticals, Inc. (FURX) | 28-Feb-14 | Grant | 3,580 | -- | -- | 62% 5.73K to 9.31K | |
| 29-May-13 8:40 PM View: | Furiex Pharmaceuticals, Inc. (FURX) | 24-May-13 | Grant | 5,728 | -- | -- | 100% 0 to 5.73K | |
| 20-Jun-12 6:46 PM View: | Ardea Biosciences, Inc. (RDEA) | 19-Jun-12 | Disposition | 16,099 | $32.00 | $515,168.00 | (100%) 16.1K to 0 | < 1% |
| 08-Jun-12 7:02 PM View: | Ardea Biosciences, Inc. (RDEA) | 06-Jun-12 | Payment of Exercise | 191 | $31.96 | $6,104.36 | (1%) 16.01K to 15.82K | 0% |
| 07-May-12 7:25 PM View: | Ardea Biosciences, Inc. (RDEA) | 06-May-12 | Payment of Exercise | 191 | $31.70 | $6,054.70 | (1%) 15.6K to 15.41K | < 1% |
| 06-Apr-12 7:35 PM View: | Ardea Biosciences, Inc. (RDEA) | 06-Apr-12 | Payment of Exercise | 191 | $21.92 | $4,186.72 | (1%) 15.79K to 15.6K | 0% |
| 07-Mar-12 7:59 PM View: | Ardea Biosciences, Inc. (RDEA) | 06-Mar-12 | Payment of Exercise | 213 | $20.33 | $4,330.29 | (1%) 16.0K to 15.79K | 0% |
| 08-Feb-12 6:27 PM View: | Ardea Biosciences, Inc. (RDEA) | 06-Feb-12 | Payment of Exercise | 218 | $20.20 | $4,403.60 | (1%) 16.22K to 16.0K | 2% |
| 06-Jan-12 7:48 PM View: | Ardea Biosciences, Inc. (RDEA) | 06-Jan-12 | Payment of Exercise | 218 | $15.55 | $3,389.90 | (1%) 17.14K to 16.92K | (4%) |
| 06-Jan-12 7:48 PM View: | Ardea Biosciences, Inc. (RDEA) | 06-Jan-12 | Market Sale (Planned) | 700 | $15.91 | $11,138.00 | (4%) 16.92K to 16.22K | (1%) |
| 08-Dec-11 7:40 PM View: | Ardea Biosciences, Inc. (RDEA) | 06-Dec-11 | Payment of Exercise | 191 | $19.93 | $3,806.63 | (1%) 17.33K to 17.14K | 2% |
| 17-Nov-11 7:28 PM View: | Ardea Biosciences, Inc. (RDEA) | 15-Nov-11 | Market Sale (Planned) | 432 | $18.86 | $8,145.92 | (2%) 17.76K to 17.33K | < 1% |
| 08-Nov-11 8:53 PM View: | Ardea Biosciences, Inc. (RDEA) | 06-Nov-11 | Payment of Exercise | 191 | $18.81 | $3,592.71 | (1%) 17.38K to 17.19K | (< 1%) |
| 07-Oct-11 9:12 PM View: | Ardea Biosciences, Inc. (RDEA) | 06-Oct-11 | Payment of Exercise | 191 | $15.73 | $3,004.43 | (1%) 18.27K to 18.08K | (< 1%) |